Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

What symbol and exchange does Longeveron - Class A shares trade?

Longeveron - Class A trades on the NASDAQ stock market under the symbol LGVN.

What is Longeveron - Class A stock price doing today?

As of November 2, 2026, LGVN stock price climbed to $1.71 with 58,476 million shares trading.

What is Longeveron - Class A's Beta?

LGVN has a beta of 2.00, meaning it tends to be more sensitive to market movements. LGVN has a correlation of 0.02 to the broad based SPY ETF.

How much is Longeveron - Class A worth?

LGVN has a market cap of $5.45 million. This is considered a Sub-Micro Cap stock.

How much money does Longeveron - Class A make?

Last quarter Longeveron - Class A reported $287,000 in Revenue and -$1.90 earnings per share. This fell short of revenue expectation by $-39,800 and met earnings estimates .

What is the highest and lowest price Longeveron - Class A traded in the last 3 year period?

In the last 3 years, LGVN traded as high as $239.00 and as low as $1.31.

What are the top ETFs holding Longeveron - Class A?

The top ETF exchange traded funds that LGVN belongs to (by Net Assets): VXF, VTI.

Is Longeveron - Class A (LGVN) a good investment?

LGVN has underperformed the market in the last year with a return of -79.6%, while the SPY ETF gained +11.7%. In the last 3 month period, LGVN fell short of the market, returning -74.7%, while SPY returned +1.7%. However, in the most recent 2 weeks LGVN has outperformed the stock market by returning +23.0%, while SPY returned -1.5%.

What are the support and resistance levels for Longeveron - Class A (LGVN)?

LGVN support price is $1.53 and resistance is $1.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LGVN shares will trade within this expected range on the day.